Leslie Walker

New regulations designed to crack down on misleading marketing of Medicare insurance plans face their first big test when seniors begin shopping for coverage on Oct. 15.

A bipartisan group of lawmakers agree: Medicare and Medicaid are failing 12 million of the country's most vulnerable patients.

For the first time in its 58-year history, Medicare, the public health insurance program for seniors, will have the power to ask for price cuts from drugmakers thanks to the Inflation Reduction Act passed last year.

What’s a fair price to pay for prescription drugs? Medicare will soon face this and other tough questions when it begins historic price negotiations with drugmakers.

The rapid growth of private Medicare Advantage plans is raising questions about what care could — and should — look like for all 80 million people expected to be on Medicare by 2030.

Congress is considering legislation that would cut the prices Medicare pays hospitals for some common outpatient services like X-rays, injections and check-ups.

A federal pilot project tests handing the reins of some hospice care over to private insurers. The experiment, which began in 2021, could ultimately transform the end of life care available to millions of Americans.

After 20 years and $200 billion in revenue, Humira — an injectable treatment for autoimmune conditions like rheumatoid arthritis — is losing its monopoly.

Professor Karen Bullock has spent the last two decades studying what stops seriously ill Black patients and their families from getting the care they want in life and in death.

The pandemic has reignited long-standing turf wars among health professions, and state lawmakers are caught in the middle.